| pubmed-article:16731287 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16731287 | lifeskim:mentions | umls-concept:C0663241 | lld:lifeskim |
| pubmed-article:16731287 | lifeskim:mentions | umls-concept:C0449297 | lld:lifeskim |
| pubmed-article:16731287 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:16731287 | lifeskim:mentions | umls-concept:C0206075 | lld:lifeskim |
| pubmed-article:16731287 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16731287 | pubmed:dateCreated | 2006-5-29 | lld:pubmed |
| pubmed-article:16731287 | pubmed:abstractText | Linezolid is being used increasingly for life-threatening vancomycin-resistant infections in critically ill patients. Limited data suggest that linezolid is cleared by intermittent hemodialysis. However, information on clearance of linezolid by continuous renal replacement therapy is limited. A patient undergoing continuous venovenous hemodiafiltration (CVVHDF) was evaluated to determine linezolid clearance through CVVHDF. | lld:pubmed |
| pubmed-article:16731287 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16731287 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16731287 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16731287 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16731287 | pubmed:issn | 1523-6838 | lld:pubmed |
| pubmed-article:16731287 | pubmed:author | pubmed-author:PeloquinCharl... | lld:pubmed |
| pubmed-article:16731287 | pubmed:author | pubmed-author:MalhotraDeepa... | lld:pubmed |
| pubmed-article:16731287 | pubmed:author | pubmed-author:MauroLaurie... | lld:pubmed |
| pubmed-article:16731287 | pubmed:author | pubmed-author:SchmudeKimber... | lld:pubmed |
| pubmed-article:16731287 | pubmed:author | pubmed-author:AssalyRaghebR | lld:pubmed |
| pubmed-article:16731287 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16731287 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:16731287 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16731287 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16731287 | pubmed:pagination | e83-6 | lld:pubmed |
| pubmed-article:16731287 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:meshHeading | pubmed-meshheading:16731287... | lld:pubmed |
| pubmed-article:16731287 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16731287 | pubmed:articleTitle | Clearance of linezolid via continuous venovenous hemodiafiltration. | lld:pubmed |
| pubmed-article:16731287 | pubmed:affiliation | University of Toledo College of Pharmacy, OH, USA. lmauro@utnet.utoledo.edu | lld:pubmed |
| pubmed-article:16731287 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16731287 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:16731287 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
